Cochrane · systematic review · CD013496

Intermittent fasting for the prevention of cardiovascular disease

Allaf, M, Elghazaly, H, Mohamed, OG, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

HeartAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
24
current version
GRADE rated
6
No studies
18
Included studies
NR
No studies 18 · 75%Ungraded 0 · 0%Very low 3 · 12.5%Low 3 · 12.5%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

IF compared to ad libitum (short term) for the prevention of cardiovascular disease

Population: the prevention of cardiovascular disease
8 questions
OutcomeEffectEvidenceStatus / GRADE
Outcomes (4 to 12 weeks
IF vs ad libitum (short term)
no estimate extractedNRNo studies
All‐cause mortality
IF vs ad libitum (short term)
no estimate extractedNRNo studies
CV Mortality
IF vs ad libitum (short term)
no estimate extractedNRNo studies
Stroke
IF vs ad libitum (short term)
no estimate extractedNRNo studies
MI
IF vs ad libitum (short term)
no estimate extractedNRNo studies
Heart failure
IF vs ad libitum (short term)
no estimate extractedNRNo studies
Absolute change in body weight (kg) (4 to 12 weeks
IF vs ad libitum (short term)
no estimate extracted7 studies · 224 participantsLow
Downgraded: inconsistency
Absolute change in Glucose (mmol/L) (8 to 12 weeks
IF vs ad libitum (short term)
no estimate extracted3 studies · 95 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency

IF compared to CER (short term) for the prevention of cardiovascular disease

Population: the prevention of cardiovascular disease
8 questions
OutcomeEffectEvidenceStatus / GRADE
Outcomes (4 to 12 weeks
IF vs CER (short term)
no estimate extractedNRNo studies
All‐cause mortality
IF vs CER (short term)
no estimate extractedNRNo studies
CV Mortality
IF vs CER (short term)
no estimate extractedNRNo studies
Stroke
IF vs CER (short term)
no estimate extractedNRNo studies
MI
IF vs CER (short term)
no estimate extractedNRNo studies
Heart failure
IF vs CER (short term)
no estimate extractedNRNo studies
Absolute change in body weight (kg) (4 to 12 weeks
IF vs CER (short term)
no estimate extracted10 studies · 719 participantsVery low
Downgraded: inconsistency
Absolute change in Glucose (mmol/L) (4 to 12 weeks
IF vs CER (short term)
no estimate extracted9 studies · 582 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency

IF compared to CER (medium term) for the prevention of cardiovascular disease

Population: the prevention of cardiovascular disease
8 questions
OutcomeEffectEvidenceStatus / GRADE
Outcomes (4 months ‐ 6 months
IF vs CER (medium term)
no estimate extractedNRNo studies
All‐cause mortality
IF vs CER (medium term)
no estimate extractedNRNo studies
CV Mortality
IF vs CER (medium term)
no estimate extractedNRNo studies
Stroke
IF vs CER (medium term)
no estimate extractedNRNo studies
MI
IF vs CER (medium term)
no estimate extractedNRNo studies
Heart failure
IF vs CER (medium term)
no estimate extractedNRNo studies
Absolute change in body weight (kg) (4 months ‐ 6 months
IF vs CER (medium term)
no estimate extracted4 studies · 279 participantsLow
Downgraded: risk of bias
Absolute change in glucose (mmol/L) (4 months ‐ 6 months
IF vs CER (medium term)
no estimate extracted4 studies · 279 participantsLow
Downgraded: risk of bias